2/17/23 17:17 | 2/3/21 | SANA | Sana Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Bilenker Joshua H. | WA | D | | P | 500 | 25.00 | 0 | 20 | New | 20 | D | | | | | | | | | | | | | | |
1/17/19 08:06 | 7/9/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.a | 9 | 1.18 | 0 | 8 | 6 | 141 | D | | | | | | | | | | | | | | |
12/12/18 17:12 | 12/10/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 273 | 13.67 | 0 | 20 | 11 | 194 | D | | | | | | | | | | | | | | |
12/12/18 17:12 | 12/10/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -2,709 | 135.47 | 0 | -20 | -9 | 194 | D | | | | | | | | | | | | | | |
11/28/18 17:08 | 11/26/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 222 | 4.54 | 0 | 49 | 34 | 194 | D | | | | | | | | | | | | | | |
11/28/18 17:08 | 11/26/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -2,945 | 147.26 | 0 | -20 | -9 | 194 | D | | | | | | | | | | | | | | |
10/5/18 16:42 | 10/3/01 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 73 | 3.65 | 0 | 20 | 14 | 165 | D | | | | | | | | | | | | | | |
10/5/18 16:42 | 10/3/01 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -3,299 | 164.94 | 0 | -20 | -11 | 165 | D | | | | | | | | | | | | | | |
9/14/18 18:17 | 9/12/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 30 | 1.50 | 0 | 20 | 14 | 165 | D | | | | | | | | | | | | | | |
9/14/18 18:17 | 9/12/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -3,324 | 166.20 | 0 | -20 | -11 | 165 | D | | | | | | | | | | | | | | |
8/15/18 17:23 | 8/13/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 24 | 1.18 | 0 | 20 | 14 | 165 | D | | | | | | | | | | | | | | |
8/15/18 17:23 | 8/13/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -3,188 | 159.41 | 0 | -20 | -11 | 165 | D | | | | | | | | | | | | | | |
7/11/18 17:01 | 7/9/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 18 | 1.18 | 0 | 15 | 10 | 165 | D | | | | | | | | | | | | | | |
7/11/18 17:01 | 7/9/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -2,752 | 183.48 | 0 | -15 | -8 | 165 | D | | | | | | | | | | | | | | |
6/21/18 17:02 | 6/19/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 51 | 1.18 | 0 | 43 | 36 | 164 | M | | | | | | | | | | | | | | |
6/21/18 17:02 | 6/19/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -10,181 | 178.62 | 0 | -57 | -26 | 164 | M | | | | | | | | | | | | | | |
5/16/18 16:44 | 5/14/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 18 | 1.18 | 0 | 15 | 9 | 183 | D | | | | | | | | | | | | | | |
5/16/18 16:44 | 5/14/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -2,048 | 136.51 | 0 | -15 | -8 | 183 | D | | | | | | | | | | | | | | |
4/26/18 16:31 | 4/24/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 18 | 1.18 | 0 | 15 | 9 | 183 | D | | | | | | | | | | | | | | |
4/26/18 16:31 | 4/24/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -1,967 | 131.12 | 0 | -15 | -8 | 183 | D | | | | | | | | | | | | | | |
3/15/18 17:00 | 3/13/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 18 | 1.18 | 0 | 15 | 9 | 183 | D | | | | | | | | | | | | | | |
3/15/18 17:00 | 3/13/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -1,973 | 131.54 | 0 | -15 | -8 | 183 | D | | | | | | | | | | | | | | |
2/14/18 17:36 | 2/12/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 18 | 1.18 | 0 | 15 | 9 | 183 | D | | | | | | | | | | | | | | |
2/14/18 17:36 | 2/12/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -1,449 | 96.57 | 0 | -15 | -8 | 183 | D | | | | | | | | | | | | | | |
1/18/18 17:01 | 1/16/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 18 | 1.18 | 0 | 15 | 9 | 183 | D | | | | | | | | | | | | | | |
1/18/18 17:01 | 1/16/18 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -1,323 | 88.21 | 0 | -15 | -8 | 183 | D | | | | | | | | | | | | | | |
12/18/17 17:40 | 12/14/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 18 | 1.18 | 0 | 15 | 9 | 183 | D | | | | | | | | | | | | | | |
12/18/17 17:40 | 12/14/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -1,217 | 81.12 | 0 | -15 | -8 | 183 | D | | | | | | | | | | | | | | |
11/29/17 17:17 | 11/27/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 18 | 1.18 | 0 | 15 | 9 | 183 | D | | | | | | | | | | | | | | |
11/29/17 17:17 | 11/27/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -1,117 | 74.45 | 0 | -15 | -8 | 183 | D | | | | | | | | | | | | | | |
11/1/17 17:03 | 10/30/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 18 | 1.18 | 0 | 15 | 9 | 189 | D | | | | | | | | | | | | | | |
11/1/17 17:03 | 10/30/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -1,303 | 86.84 | 0 | -15 | -7 | 189 | D | | | | | | | | | | | | | | |
9/20/17 17:04 | 9/18/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 18 | 1.18 | 0 | 15 | 9 | 189 | D | | | | | | | | | | | | | | |
9/20/17 17:04 | 9/18/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -1,335 | 89.02 | 0 | -15 | -7 | 189 | D | | | | | | | | | | | | | | |
8/16/17 17:20 | 8/14/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | M.dm | 18 | 1.18 | 0 | 15 | 9 | 189 | D | | | | | | | | | | | | | | |
8/16/17 17:20 | 8/14/17 | LOXO | Loxo Oncology, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bilenker Joshua H. | CT | DO | P,CEO | S.dm | -1,103 | 73.56 | 0 | -15 | -7 | 189 | D | | | | | | | | | | | | | | |